Testing for Sexually Transmitted Infections via the Internet

Posted on

Commentary by Charlotte Gaydos, MS, MPH, DrPH, Johns Hopkins University Sexually transmitted infections (STIs) are a significant health burden in the United States, having an estimated prevalence of over 110 million, with approximately 19 million incident infections annually.1 The most common bacterial infection of these is caused by Chlamydia trachomatis with 1,441,789 cases reported to […]

Approaches to Delivering Partner Treatment

Posted on

Commentary by Catherine Lindsey Satterwhite, PhD, MSPH, MPH In the October 2011 issue of Sexually Transmitted Diseases, Yu and colleagues report on an evaluation of partner services delivered in eight family planning clinics in California. From 2005–2006, researchers interviewed females aged 16–35 years who were diagnosed with chlamydia to ascertain what partner services were received […]

Why do I need to retest after treatment?

Posted on

Chlamydial reinfections are very common—as many as 1 in 5 people will have a repeat infection with chlamydia within the first few months after they are treated for their initial infection. Untreated chlamydia can increase a woman’s risk for developing: pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. In fact, women who […]

Tips for Communicating about Sexual Health

Posted on

Below are recommendations and information that can help you talk to patients in a sensitive, open, and non-judgmental manner. Avoid asking questions in a way that implies there is a right or wrong answer, such as: “You always use condoms, right?” or “You don’t have partners outside your marriage, do you?” Be specific about how […]

Presentations from the 2016 STD Prevention Conference

Posted on

New Directions in Adolescent Risk What’s Different about Detroit’s School Screening Program? Research Aimed at Explaining Results Showing 5 Consecutive Years of Declines in CT Prevalence Detroit’s school-based STD screening program is the first such program to be associated with a sustained reduction in chlamydia prevalence. Richard Louis Dunville, MPH, Division of Adolescent and School […]

Many with Chlamydia Fail to Receive Recommended Retest

Posted on

Commentary by Karen Hoover, MD, MPH Retesting for chlamydia several months after treatment is important, because a large percentage of persons will become reinfected by an untreated partner or by a new, infected one. Repeated chlamydial infections in women can increase their risk of pelvic inflammatory disease and its ad-verse outcomes of infertility, and ectopic […]

Extra-Genital Chlamydia and Gonorrhea Infections

Posted on

By John Papp, PhD Chlamydia and gonorrhea infections are common in non-genital sites in some populations such as men who have sex with men (MSM). Be-cause extra-genital infections are common in MSM and most infections are asymptomatic1, routine annual screening of extra-genital sites in MSM is recommended. No recommendations exist regarding routine extra-genital screening in […]

Updates to the USPSTF Chlamydia Screening Guidelines: A Delicate Balance Between Evidence and Action

Posted on

Commentary by Joan M. Chow, MPH, DrPH, Chief, Surveillance, Epidemiology, Assessment, and Evaluation Section, California Department of Public Health-Sexually Transmitted Disease Control Branch Although over 1.4 million chlamydia cases were reported to the Centers for Disease Control and Prevention (CDC) in 2013, there are potentially two to three times that number of infections as a […]